CAZZANIGA, MARINA ELENA

CAZZANIGA, MARINA ELENA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 104 (tempo di esecuzione: 0.031 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 01 - Articolo su rivista 2022 Gerussi, AlessioBiondi, AndreaBinatti, EleonoraBellani, GiacomoBellelli, GiuseppeCiterio, GiuseppeFoti, GiuseppeBettini, Laura RacheleValsecchi, Maria GraziaD'Angiò, MariellaCazzaniga, MarinaFaverio, PaolaBonfanti, PaoloInvernizzi, Pietro +
Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything 01 - Articolo su rivista 2022 Cazzaniga, Marina Elena +
Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic 01 - Articolo su rivista 2022 Russo, SelenaBani, MarcoTerraneo, MarcoNuvolati, GiampaoloCazzaniga, Marina ElenaStrepparava, Maria Grazia +
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19 01 - Articolo su rivista 2022 Cazzaniga, Marina EBonfanti, Paolo +
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 01 - Articolo su rivista 2022 Marina Elena CazzanigaNicoletta CordaniMaria Grazia Cerrito +
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial 01 - Articolo su rivista 2022 Cazzaniga, Marina +
Social capital and willingness to participate in COVID-19 vaccine trials: an Italian case-control study 01 - Articolo su rivista 2022 Terraneo, MarcoNuvolati, GiampaoloBani, MarcoRusso, SelenaStrepparava, Maria GraziaCazzaniga, Marina Elena +
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 01 - Articolo su rivista 2022 Pagan, EleonoraBagnardi, VincenzoCazzaniga, Marina Elena +
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 01 - Articolo su rivista 2022 Scagliotti A.Capizzi L.Cazzaniga M. E.Ilari A.Cordani N.Albini A.Lavitrano M.Grassilli E.Cerrito M. G. +
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 01 - Articolo su rivista 2022 Cicchiello F.Cordani N.Cerrito M. G.Cazzaniga M. E. +
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 01 - Articolo su rivista 2022 Cazzaniga M. E.Baroni S.Cicchiello F.Cordani N.Cerrito M. G. +
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 01 - Articolo su rivista 2021 Cazzaniga M. +
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project 01 - Articolo su rivista 2021 Cazzaniga M. E. +
Metronomic chemotherapy 01 - Articolo su rivista 2021 Cazzaniga M. E.Cordani N.Cerrito M. G. +
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 01 - Articolo su rivista 2021 Galimberti S.Valsecchi M. G.Squillace N.Cazzaniga M. E.Bonfanti P. +
Mapping the human genetic architecture of COVID-19 01 - Articolo su rivista 2021 Invernizzi, PietroGerussi, AlessioBiondi, AndreaFoti, GiuseppeValsecchi, Maria G.D’Angiò, MariellaCazzaniga, MarinaFaverio, PaolaBonfanti, PaoloCrotti, Lia